Furthermore, consistent with the expression of CCR4, malignant CD4+ T cells in most cases of MF/SS exhibit a Th2 phenotype with enhanced production of IL-4 and IL-5 [132]. The gene discussed is CD4; the disease is synovial sarcoma.